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ABSTRACT 
Polycystic ovary syndrome (PCOS) is a common heterogeneous condition in 
women of reproductive age, relating to both physical and mental health. Thoughts 
on primary pathological origins shift from the ovary to the adrenal gland. Insulin 
signaling pathways and sympathetic nerve activity are thought to be involved. 
PCOS features include signs of high androgen concentrations and 
oligo/amenorrhea. Affective symptoms such as depression and anxiety are 
prevalent among women with the syndrome and have been associated with body 
mass index (BMI). PCOS interventions are symptom-oriented and should include 
physical exercise as part of lifestyle management. Effective pharmacological 
interventions have side-effects to be taken in consideration. Previous studies 
suggest electroacupunture (EA) to modulate features commonly observed in 
women with PCOS. The general aims of this thesis were to explore self-reported 
depression and anxiety-related symptoms in women with PCOS; and to evaluate 
low-frequency EA and physical exercise on muscle sympathetic nerve activity 
(MSNA), biochemical hyperandrogenism and oligo/amenorrhea. 
Study I investigated depression and anxiety-related symptoms in women with 
PCOS and noted several anxiety symptoms to distinguish women with PCOS from 
controls matched on age, body weight and BMI. Symptoms of worry, phobias and 
sleep disturbances were overrepresented among women with PCOS and may be an 
indication of an increased arousal.  
Study II explored associations between depression and anxiety symptoms, and 
estrogens, sex steroid precursors, androgens, glucuronidated androgen metabolites, 
sex hormone-binding globulin (SHBG) and insulin sensitivity in drug-naïve 
women with PCOS. Women with depression-related symptoms had lower 
testosterone (T), free testosterone (FT) and androstane-3α 17β-diol-3glucuronide 
(3G). There were inverse associations between circulating FT, 3G and symptoms 
of depression.  
Study III aimed to evaluate low-frequency EA and physical exercise on MSNA in 
women with PCOS. Twenty women with PCOS were allocated to low-frequency 
EA, physical exercise, or no intervention. From baseline to week 16, MSNA burst 
frequency decreased by -39.4% for low-frequency EA; -39.0 % for physical 
exercise; and -8.7% for no intervention.  
Study IV investigated if low-frequency EA would decrease hyperandrogenism and 
improve oligo/amenorrhea more effectively than physical exercise or no active 
intervention in women with PCOS. Eighty four women with PCOS were 
randomized to 16 weeks of low-frequency EA, physical exercise, or no 
intervention. Circulating T, androsterone glucuronide (ADT-G) and 3G decreased 
from baseline measurements to week 16 for low-frequency EA compared to 
physical exercise. Circulating T, FT, estrone-sulfate (E1-S), ADT-G, 3G and 
androstane-3α 17β-diol-17glucuronide (17G) decreased from baseline 
measurements to week 16 for low-frequency EA compared to no intervention. The 
monthly menstrual bleeding frequency increased for low-frequency EA compared 
to physical exercise and no intervention from baseline measurements to week 16. 
Conclusions: This thesis supports the effects of low-frequency EA and physical 
exercise to be partly mediated via the sympathetic nervous system. Low-frequency 
EA may be a complement for treatment of hyperandrogenism in women with 
PCOS. With few minor adverse events of short duration for repeated low-
frequency EA and no adverse events for physical exercise, a combination of low-
frequency EA and physical exercise is recommended for treatment of 
oligo/amenorrhea in women with PCOS. With an unmet need for assessment and 
treatment of affective symptoms in women with PCOS further studies are 
warranted. 
